Author

Adrienne Heyrosa

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:mouse· 1 Approach:statistical model· 1

Frequent Co-Authors

Alan H. ShihiD· 1 shared Alice S. MimsiD· 1 shared Andrea LagansoniD· 1 shared Ann‐Kathrin EisfeldiD· 1 shared Aristotelis TsirigosiD· 1 shared Arwa Shana’ahiD· 1 shared Audrey LasryiD· 1 shared Benjamin Harris KaffenbergeriD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Alan H. ShihORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Multiomic characterization, early detection, and therapeutic targeting of myeloid sarcoma

Bettina Nadorp, Audrey Lasry, Sanam Loghavi, Ravi Patel, Hager M. Mansour, Benjamin Kelly, Christopher J. Walker, Jill L. Buss, Isaiah Boateng, Wafa Al-Santli, Zoe B. Ciantra, Rebecca J. Austin, Adrienne Heyrosa, Helee Desai, Andrea Laganson, , Ann‐Kathrin Eisfeld

This study characterizes myeloid sarcoma through multi-omic profiling, identifies RAS pathway activation as a hallmark, and shows RAS inhibition reduces tumor burden in mouse models.

bioRxiv · Dec 5, 2025 · PreprintCancer Biology